International Journal of Cancer · 2004 · 27 citations · 35 references
MedicineGeneticsOncologyCancer GeneticsDna ReplicationMolecular OncologyCancer CytogeneticsCancer EpigeneticsMalignant NeoplasmsProstate CancerAllelic Replication TimingChromosomal Segregation ErrorsDna In Situ HybridizationMethylation CapacityPeripheral Blood Lymphocyte AnalysisProstate CarcinogenesisReplication Timing In Cancer
Replication timing of the genetic material is a highly programmed process correlated with expression, stability and methylation capacity. An important aspect of that timing is the temporal order of allelic replication: a synchronous mode for biallelically expressed genes and an asynchronous for monoallelically expressed genes. Previous studies showed that malignancy is associated with changes in the inherent mode of allelic replication, and even normal cells of cancer patients display alterations in the replication of various genes. Using fluorescence in situ hybridization (FISH), we checked whether allelic-replication mode differentiates cancer patients from healthy individuals. We focused on prostate cancer (CAP), the most common diagnosed cancer and the second leading cause of cancer death in men over 50 years old. Five nonrelated genes and a nontranscribed DNA sequence associated with chromosomal segregation were used in our study. All 6 tested loci displayed in peripheral blood lymphocytes stimulated with phytohemagglutinin (PHA) of CAP patients loss of their inherent temporal order of allelic replication, coupled with aneuploidy, the outcome of chromosome malsegregation. The replication-timing modification is a reversible epigenetic alteration, evidenced by our ability to resurrect the normal pattern in all 6 tested loci by introducing an inhibitor of methyl transferase. On the other hand, the methylation-blocking agent failed to obliterate aneuploidy. The replication alteration accompanied by aneuploidy, detected in peripheral blood cells, distinguishes between CAP patients and individuals with benign prostate hyperplasia (BPH; a common disorder in elderly men) better than the routinely used blood marker, the prostate-specific antigen (PSA).
35
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
Ina Rhee, Kurtis E. Bachman, Ben Ho Park et al. · Nature · 2002 · 1.2K citations
Gene Expression Profiles in Normal and Cancer Cells
Lin Zhang, Wei Zhou, Victor E. Velculescu et al. · Science · 1997 · 1.2K citations
Loss of <i>IGF2</i> Imprinting: A Potential Marker of Colorectal Cancer Risk
Hengmi Cui, Marcia Cruz‐Correa, Francis M. Giardiello et al. · Science · 2003 · 730 citations